Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Nasogastric Tube Market: By Product Type, By Patient Type, By Tube Type, By Indication, By End User and Geography
Nasogastric Tube Market size was valued at US$ 437.57 million in 2023 and is poised to grow at a 5.6% CAGR from 2024 to 2030. According to the World Health Organization, the population aged 60 and above is expected to increase from 900 million in 2015 to 2000 million in 2050. The growing geriatric population is expected to drive the growth of the market. In line with this, the widespread occurrence of age-related illnesses necessitating specific interventions, such as nasogastric tube installation, is driving market expansion. Furthermore, the prevalence of problems in the older population, such as difficulties swallowing, malnutrition, chronic illnesses, or the need for postoperative care, acts as a growth-promoting factor. Furthermore, increased product usage as a viable technique of administering drugs to the geriatric population is driving market expansion.
The introduction of stringent regulations by countries and international entities to enforce standards for product quality, safety, and efficacy is promoting market growth. Furthermore, the fast expansion and upgrading of healthcare institutions, which provides more opportunities for the use of nasogastric tubes, is driving market growth. Moreover, increased awareness and education regarding nasogastric tubes among healthcare providers, patients, and caregivers is driving market. Aside from that, the relative affordability and cost-effectiveness of nasogastric tubes as compared to other medical procedures, making them a favoured alternative for both short-term and long-term treatment, is driving market expansion.
Study Period
2024 - 2030Base Year
2023CAGR
5.6%Largest Market
North AmericaFastest Growing Market
North America
The Market dynamics exhibit a multifaceted landscape driven by Technological breakthroughs in the field of nasogastric tubes are critical to influencing the industry. In line with this, recent advances have resulted in more complex, patient-friendly, and effective tubes. Furthermore, other innovations, including material enhancements, such as the use of biocompatible silicone or polyurethane, which promote comfort while minimizing discomfort, are positively influencing market growth. Moreover, the emergence of upgraded designs with specific features that enable for more precise implantation, avoiding potential problems, is helping to drive market expansion.
Furthermore, new advances in radiological techniques that assist healthcare providers in optimal tube positioning and monitoring are expected to fuel the market revenue. Aside from that, new technologies enable the integration of nasogastric tubes with other medical devices and systems for improved patient care, increased prevalence of chronic diseases such as gastrointestinal disorders, cancer, and diabetes is significantly influencing the need for nasogastric tubes, which are critical in giving nourishment and drugs as well as providing gastric decompression for patients with chronic illnesses. Furthermore, chronic diseases frequently necessitate hospitalization and extended medical care, with nasogastric tubes serving as a regular treatment technique. They are also commonly used to treat difficulties caused by surgical operations, blockages, or serious disorders affecting the digestive system. As a result, the rising frequency of chronic diseases is pushing the widespread use of nasogastric tubes in numerous healthcare settings.
However, restraints such as the possibility of skin irritation and infections because of nasogastric procedures caused by incorrect sterilization and tube displacement may hamper market expansion. Furthermore, the high intensity of suction of these tubes during stomach waste evacuation has the potential to injure the gastric mucosa and cause bleeding, which would be another impediment to the nasogastric tube market. Also, prominent companies throughout the world are focused on a variety of strategic initiatives such as new product launches, growth, and mergers and acquisitions to increase their market dominance. For example, in May 2021, QMD increased their enteral feeding portfolio by introducing the Degania range of Bi-Port and Single-Port Feeding Tubes for Nasogastric feeding.
The market is being driven by a substantial trend, with an increasing emphasis on biocompatible materials, particularly silicone, to improve patient comfort and reduce problems. This move demonstrates a dedication to improve patients' entire experiences, which is consistent with the industry's development of technologies that promote safety and well-being. The use of such materials demonstrates the nasogastric tube industry's responsiveness to patient needs and commitment to offering sophisticated, comfortable medical treatment. For example, in March 2023, Fortune® Medical announced two new products: a silicone gastrostomy tube and a silicone nasogastric tube, both of which featured the ENFit connector. The ENFit connector meets the ISO 80369-3 standard for small-bore connectors intended for liquids and gases, ensuring compatibility and safety in medical applications.
Report Benchmarks |
Details |
Report Study Period |
2024 - 2030 |
Market Size in 2023 |
US$ 437.57 million |
Market CAGR |
5.6% |
By Type |
|
By Patient Group |
|
By End User |
|
By Region |
|
Download Free Sample Report
The Nasogastric Market was valued at US$ 437.57 million in 2023 and is poised to grow at a 5.6% CAGR over the Forecast period from 2024 to 2030.
The growing geriatric population around the world, rapid technological advancements, the rising prevalence of chronic diseases, the implementation of strict regulations by governments and international bodies, and the rapid expansion and modernization of healthcare facilities are all major factors driving the market.
The market is being driven by a substantial trend, with an increasing emphasis on biocompatible materials, particularly silicone, to improve patient comfort and reduce problems. The use of such materials demonstrates the nasogastric tube industry's responsiveness to patient needs and commitment to offering sophisticated, comfortable medical treatment.
Market research is segmented based on based on product type, patient type, tube type, Indication, end user and region.
North America is estimated to largest market with the highest CAGR over the forecast period.
1. Executive Summary |
2. Global Nasogastric Tube Market Introduction |
2.1. Global Nasogastric Tube Market Taxonomy |
2.2. Global Nasogastric Tube Market Definitions |
2.2.1. By Type |
2.2.2. By Patient Group |
2.2.3. By End User |
2.2.4. By Region |
3. Global Nasogastric Tube Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Nasogastric Tube Market Dynamic Factors - Impact Analysis |
3.6. Global Nasogastric Tube Market Competition Landscape |
4. Global Nasogastric Tube Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 |
4.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Nasogastric Tube Market, By Type, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1. Levin Tube |
5.1.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Salem Sump Tube |
5.2.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Moss Tube |
5.3.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Others |
5.4.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6. Global Nasogastric Tube Market, By Patient Group, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1. Pediatric |
6.1.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Adult |
6.2.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Nasogastric Tube Market Forecast, By End User, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1. Hospitals |
7.1.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Clinics |
7.2.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Ambulatory Surgical Centers |
7.3.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Nasogastric Tube Market Forecast, By Region, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1. North America |
8.1.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
8.5.1. Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Nasogastric Tube Market - Opportunity Analysis Index, By Type, By Patient Group, By End User and Region, 2024 - 2030 |
9. North America Nasogastric Tube Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1. Type Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Levin Tube |
9.1.2. Salem Sump Tube |
9.1.3. Moss Tube |
9.1.4. Others |
9.2. Patient Group Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Pediatric |
9.2.2. Adult |
9.3. End User Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.3.1. Hospitals |
9.3.2. Clinics |
9.3.3. Ambulatory Surgical Centers |
9.3.4. Others |
9.4. Country Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. USA |
9.4.2. Canada |
9.5. North America Nasogastric Tube Market - Opportunity Analysis Index, By Type, By Patient Group, By End User and Country, 2024 - 2030 |
9.6. North America Nasogastric Tube Market Dynamics Trends |
10. Europe Nasogastric Tube Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.1. Type Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Levin Tube |
10.1.2. Salem Sump Tube |
10.1.3. Moss Tube |
10.1.4. Others |
10.2. Patient Group Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Pediatric |
10.2.2. Adult |
10.3. End User Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Hospitals |
10.3.2. Clinics |
10.3.3. Ambulatory Surgical Centers |
10.3.4. Others |
10.4. Country Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Spain |
10.4.5. Italy |
10.4.6. Russia |
10.4.7. Rest of Europe |
10.5. Europe Nasogastric Tube Market - Opportunity Analysis Index, By Type, By Patient Group, By End User and Country, 2024 - 2030 |
10.6. Europe Nasogastric Tube Market Dynamics Trends |
11. Asia-Pacific Nasogastric Tube Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
11.1. Type Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Levin Tube |
11.1.2. Salem Sump Tube |
11.1.3. Moss Tube |
11.1.4. Others |
11.2. Patient Group Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Pediatric |
11.2.2. Adult |
11.3. End User Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Hospitals |
11.3.2. Clinics |
11.3.3. Ambulatory Surgical Centers |
11.3.4. Others |
11.4. Country Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. China |
11.4.2. India |
11.4.3. Japan |
11.4.4. ASEAN |
11.4.5. Australia & New Zealand |
11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Nasogastric Tube Market - Opportunity Analysis Index, By Type, By Patient Group, By End User and Country, 2024 - 2030 |
11.6. Asia-Pacific Nasogastric Tube Market Dynamics Trends |
12. Latin America Nasogastric Tube Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
12.1. Type Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Levin Tube |
12.1.2. Salem Sump Tube |
12.1.3. Moss Tube |
12.1.4. Others |
12.2. Patient Group Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Pediatric |
12.2.2. Adult |
12.3. End User Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Hospitals |
12.3.2. Clinics |
12.3.3. Ambulatory Surgical Centers |
12.3.4. Others |
12.4. Country Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Mexico |
12.4.3. Argentina |
12.4.4. Rest of Latin America |
12.5. Latin America Nasogastric Tube Market - Opportunity Analysis Index, By Type, By Patient Group, By End User and Country, 2024 - 2030 |
12.6. Latin America Nasogastric Tube Market Dynamics Trends |
13. Middle East and Africa Nasogastric Tube Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
13.1. Type Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Levin Tube |
13.1.2. Salem Sump Tube |
13.1.3. Moss Tube |
13.1.4. Others |
13.2. Patient Group Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Pediatric |
13.2.2. Adult |
13.3. End User Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.3.1. Hospitals |
13.3.2. Clinics |
13.3.3. Ambulatory Surgical Centers |
13.3.4. Others |
13.4. Country Analysis 2024 - 2030 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Gulf Cooperation Council (GCC) Countries |
13.4.2. Israel |
13.4.3. South Africa |
13.4.4. Rest of MEA |
13.5. MEA Nasogastric Tube Market - Opportunity Analysis Index, By Type, By Patient Group, By End User and Country, 2024 - 2030 |
13.6. MEA Nasogastric Tube Market Dynamics Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Offerings, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. Andersen Products Inc. |
14.2.2. Bicakcilar A.S. |
14.2.3. C.R. Bard Medical |
14.2.4. Degania Silicone Ltd., |
14.2.5. Pacific Hospital Supply Co. Ltd |
14.2.6. Cardinal Health |
14.2.7. Guangdong Baihe Medical Technology |
14.2.8. Rontis Medical |
14.2.9. Poly Medicure Limited |
14.2.10. SecurMed |
15. Research Methodology |
16. Key Assumptions and Acronyms |
Key Market Players